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Abstract
Background: While the use of prescribing safety indicators (PSI) can reduce potentially hazardous 
prescribing, there is a need to identify actionable strategies for the successful implementation and 
sustainable delivery of PSI- based interventions in general practice.
Aim: To identify strategies for the successful implementation and sustainable use of PSI- based 
interventions in routine primary care.
Design & setting: Qualitative study in primary care settings across England.
Method: Anchoring on a complex pharmacist- led IT- based intervention (PINCER) and clinical decision 
support (CDS) for prescribing and medicines management, a qualitative study was conducted using 
sequential, multiple methods. The methods comprised documentary analysis, semi- structured 
interviews, and online workshops to identify challenges and possible solutions to the longer- 
term sustainability of PINCER and CDS. Thematic analysis was used for the documentary analysis 
and stakeholder workshops, while template analysis was used for the semi- structured interviews. 
Findings across the three methods were synthesised using the RE- AIM (reach, efficacy, adoption, 
implementation, and maintenance) framework.
Results: Forty- eight documents were analysed, and 27 interviews and two workshops involving 20 
participants were undertaken. Five main issues were identified, which aligned with the adoption and 
maintenance dimensions of RE- AIM: fitting into current context (adoption); engaging hearts and 
minds (maintenance); building resilience (maintenance); achieving engagement with secondary care 
(maintenance); and emphasising complementarity (maintenance).
Conclusion: Extending ownership of prescribing safety beyond primary care- based pharmacists, and 
achieving greater alignment between general practice and hospital prescribing safety initiatives, is 
fundamental to achieve sustained impact of PSI- based interventions in primary care.
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How this fits in
The use of PSI has been shown to be effective at reducing potentially hazardous prescribing in general 
practice. There, however, remains a need to identify actionable strategies to maximise the reach 
and achieve longer- term sustainability of PSI- based interventions. Previous studies have shown the 
following to be important: availability of resources; simplifying the use of interventions; avoiding 
alert fatigue; pharmacist embedment; and improving the specificity of PSIs. This qualitative study 
synthesises findings from a documentary analysis, interviews, and workshops with local, regional, and 
national primary care stakeholders, to draw lessons from the implementation of a complex PINCER 
and CDS. This results in five strategies centering around engagement with the primary care team and 
alignment of policies to achieve sustainable use of PSI- based interventions.
Introduction
Prescribing and medication errors are common in primary care. Although many are not serious, they 
overall — as a function of the substantial volume of prescribing in this setting — are responsible for 
considerable potentially avoidable harm.1 There is evidence from the authors' work and others that 
focusing on PSI offers an opportunity to reduce the frequency of these errors, which may also translate 
into improved health outcomes.2,3 These indicators have been embedded in technology- enabled 
interventions to improve prescribing safety in primary care such as CDS and PINCER,4 both of which 
have demonstrated positive impact in reducing the rate of potentially hazardous prescribing in primary 
care.2,4,5 CDS systems are often used in primary care for support in decision making for prescribers 
at the point of prescribing. They provide patient- related information and clinical knowledge to 
enhance patient care, and may reduce medication error or the potential prescribing of inappropriate 
medications. Alternatively, PINCER is a pharmacist- led intervention that involves a search of patient 
records to identify those at risk of potentially hazardous prescribing and/or monitoring errors based 
on PSIs built into the software, and an educational outreach programme for general practice staff. 
Figure 1 Summary of pharmacist- led IT- based intervention (PINCER) in general practice
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Further details on how the PINCER and CDS interventions occur in general practice are outlined in 
Figures 1 and 2.
There remains, however, a need to better understand how these approaches, centred on CDS 
and expert pharmacist input, might be both scaled up and systematised into routine clinical practice. 
The avoiding patient harm through the application of prescribing safety indicators in English general 
practices (PRoTeCT) research programme aims to evaluate PINCER and CDS systems to respond to 
the international call made for evidence through the World Health Organization’s (WHO's) third global 
patient safety challenge: ‘Medication without harm’6 and national drivers.7 In this article, strategies 
are outlined for the successful sustainment, reach, and optimisation of PSI- based interventions in 
primary care by drawing lessons learnt from the longer- term implementation of PINCER and CDS 
across England.
Figure 2 Summary of clincial decision support (CDS) interventions in general practice
Shamsuddin A et al. BJGP Open 2021; DOI: 10.3399/BJGPO.2021.0109
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Method
A qualitative study was undertaken using sequential, multiple methods, comprising a documentary 
analysis, in- depth qualitative interviews, and participatory workshops. These three interlinked phases 
produced findings that were synthesised using the RE- AIM framework8 to consolidate learning on the 
various key factors that influence the sustained implementation of the PINCER and CDS interventions.
Phase 1: Documentary analysis
A scoping search was conducted with the aim of identifying important factors influencing the 
sustainable adoption of PSI- based interventions in primary care. Ovid MEDLINE and Google Scholar 
were searched using the terms: 'healthcare information technolog*'; or 'primary care'; or 'prescribing 
safety'; or 'prescribing safety indicator*'; or 'implementation'; or 'evaluation', with no date restrictions 
up to September 2020. The eligibility criteria included documents that discussed implementation 
and/or sustainability of PSI- based interventions in primary care. To provide context, articles on the 
implementation or evaluation of similar interventions in primary care that aimed to improve prescribing 
safety, such as e- prescribing, medication reconciliation technology, and other interventions, were 
reviewed. Articles not in English were excluded.
Thirty- eight papers met the eligibility criteria and an additional 10 documents relating to 
publications from relevant professional bodies and reports on previous rollouts of the interventions 
(for example, from Academic Health Science Networks, clinical commissioning groups, and software 
developers) were suggested by topic experts within the research team and included to give a total of 
48 documents. These consisted of peer reviewed research articles, reports to funders, NHS guidance 
and briefing documents, professional standards guidance, expert- written articles, and both analysed 
and unanalysed data from the PRoTeCT research team.
One author, a post- doctoral research fellow experienced in qualitative research, analysed the data 
thematically by extracting data on issues affecting implementation, sustainability, and reach of the 
interventions to produce thematic findings. This thematic analysis was completed in parallel with 
a review of the implementation science and adoption of complex interventions literature to ensure 
important themes in the data were considered alongside relevant theoretical frameworks. Thematic 
findings from the documentary analysis were used to generate the subsequent interview guide and to 
build on the initial coding framework for stakeholder interviews.
Phase 2: Stakeholder interviews
Twenty- seven virtual semi- structured interviews were held via Microsoft Teams (in compliance with 
restrictions to travel and in- person meetings in the context of the COVID-19 pandemic). Interviews 
were conducted by a postdoctoral researcher with a nursing background outside of the UK. Participants 
were eligible if they had either had direct contact with, understood, and/or were in a position to 
influence wider or sustained adoption of the PINCER and CDS interventions at local, regional, or 
national levels.
Sampling began purposively using existing networks of the research team. It then proceeded to 
snowball sampling, building on the networks of participants and fulfilling the needs of the data in 
gaining the perspectives of significant stakeholders in prescribing safety in primary care until data 
saturation was reached at 27 interviews. Interviews were guided by a topic guide from a synthesis 
of the above- mentioned documentary analysis findings. Interviews lasted 20–90 min, were digitally 
audiorecorded, and transcribed by an approved transcribing service. Each participant was interviewed 
only once.
Analysis of interviews was data driven using template analysis9 and emerging key themes were 
mapped to the RE- AIM framework.8 NVivo (version 12) was used to manage the data and one author 
coded the data. The coding framework and nine transcripts were reviewed by a further author for 
second coding and internal validity. Key themes emerging from the data were discussed and agreed by 
the research team at regular meetings. Interview findings were presented at the stakeholder workshops 
for discussion and comments to generate strategies for scaling- up and enhancing sustainability.
Phase 3: Stakeholder workshops
The aim of the workshops was to generate recommendations for optimising the use and impact of the 
CDS and PINCER interventions by discussing issues that affect the reach, adoption, and sustainable 
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delivery of the interventions across primary care in England. Two stakeholder workshops were held 
2 weeks apart, consisting of 11 participants in the first workshop and nine in the second workshop. 
Participants from the previous interview phase were invited via email and asked to disseminate the 
invitation email to their networks. Patient and public involvement (PPI) groups were also approached 
for participation and invitation emails were also sent to 952 PINCER users who had given consent 
to be contacted for research purposes. Participants in each workshop were assigned to groups of 
three or four and discussed three topics with facilitation by three authors. Topics of discussion for the 
first workshop were developed from findings of the interviews. The topics for the second workshop 
were developed from findings of the first workshop to further explore issues raised by participants 
alongside the interview data. From their discussion of each topic, participants in groups were asked to 
select three important points to bring to the main group discussion for selection and ranking between 
all participants.
Researcher field notes and workshop artefacts (notes from group discussions and results of ranking 
exercise) were analysed thematically and compared with findings of the documentary analysis and 
stakeholder interviews. Both workshops were conducted online via Microsoft Teams and lasted 2 
hours each. Microsoft PowerPoint was used for presentations, Padlet was used for group tasks and 
discussion, and lastly, Mentimeter was used for the ranking exercise.
Results
The findings revealed five main themes describing strategies supporting sustained impact of PSI- 
based interventions, four of which mapped to the ‘maintenance’ dimension of RE- AIM, with one 
strategy mapping to the ‘adoption’ dimension. A summary of the RE- AIM framework is provided in 
Table 1. These strategies are outlined below, ranked according to priority by workshop participants, 
and examples of evidence for these strategies are presented in Supplementary Table S1.
Strategy for success #1: Fitting PSI-based interventions into the 
current context
The data indicated that fitting PSI- based interventions into the current context is key to achieving 
maximum adoption. Context was perceived to be at the micro, meso, and macro levels, in that the 
intervention had to be easy for the practice team to use (micro level), be integrated into current IT 
systems (meso level), and align to local and/or national agendas (macro level).
Facilitating ease of use for practice staff was a shared view across interview and workshop 
participants with regards to both access and use of the intervention. In the participants’ view, this 
meant making the intervention as easy to use as possible so as not to disrupt the workflow:
‘Anything that slows the consultation down isn’t often welcomed.’ (Interview participant, GP, 
professional body representative)
The importance of ease of use is further captured in the documentary analysis where it was argued, 
‘even if the cited CDS interventions are transferable, usability challenges could limit impact on health 
processes and/or outcomes‘.10
Table 1 RE- AIM framework8
Dimension Definition Contextual level
Reach
Proportion of the target population that 
participated in the intervention Individual
Efficacy Success rate if implemented as intended Individual
Adoption
Proportion of settings, practices, and plans 
that will adopt this intervention Organisational
Implementation
Extent to which the intervention is 
implemented as intended in the real world Organisational
Maintenance
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Making the intervention easy to use was closely related to interoperability or integration of 
the interventions to existing IT systems within the practice. Participants across the interviews and 
workshops believed integration of the intervention with existing IT systems would facilitate its use. 
In embedding the interventions into the IT system, the impact of the interventions need to align 
with existing local and national agendas to increase their visibility to policymakers. This alignment to 
policies could take a number of forms; for example, incentivised efforts or guidelines to best practice 
that would place the intervention as important to implement.
Additionally, workshop participants highlighted the importance of supporting local health providers 
to achieve local targets using the interventions. The support of local healthcare organisations was 
seen as essential alongside national funding for the interventions, rather than in place of, to ensure 
that each locality was sufficiently engaged and motivated to implement the interventions over time.
Strategy for success #2: Engaging hearts and minds
Data from interviews and workshops clearly indicated the need to align the impact of the interventions 
with the professional values of stakeholders in order to achieve longer- term sustainability of PSI- based 
interventions, which mapped to the ‘maintenance’ dimension of RE- AIM. This alignment involved 
engaging both emotional and cognitive aspects, by making explicit the benefits of the interventions to 
the values of implementers and users. Similarly, workshop participants who were clinicians suggested 
using the intervention for planning and prioritisation of their daily workload to generate caseloads 
according to patient risk and matching clinical capacity:
‘Clinicians have to be convinced that it is worth their while having it there and the irritations 
that it causes. If we knew for sure that it is saving X million pounds and where is that investment 
going back in to? How is that being helpful? If it is improving the quality of prescribing well let’s 
see the evidence of that being provided to us but I never see that.’ (Interview participant, GP, 
professional body representative)
Workshop and interview participants pointed out the importance of leadership in achieving longer- 
term engagement with the interventions. They envisioned PSI- based intervention ‘champions’ to be 
those in leadership or otherwise influential positions at both local and national levels, and were seen 
as vital at every level to achieve sustained engagement with the interventions by advocating for them. 
In the documentary analysis, multilevel buy- in was seen as vital for sustaining PSI- based interventions 
for the longer term, particularly in facilitating a cultural change in practice.11
Strategy for success #3: Building resilience
Across the workshops and interviews, participants outlined the importance of taking a team approach 
across health care in implementing and sustaining PINCER and CDS to ensure they became part 
of everyday practice. Participants underscored the importance of engaging across professions 
within general practice in implementing the principles of prescribing safety. They perceived this as 
an important sustainability measure to maintain PSI- based interventions over time, particularly in 
withstanding fast- paced changes. Participants generally welcomed pharmacist- led interventions for 
prescribing safety, yet importantly pointed out concerns in deskilling and change of staff that could 
affect the sustainability of the intervention(s):
‘... a concern is when the pharmacist is away, it all defaults back to the GPs again and then we 
have almost got deskilled to some extent because they have got the expertise and we haven’t.’ 
(Interview participant, GP, professional body representative)
Participants also claimed that impact was enhanced and risk reduction was increased with the 
involvement of all staff members compared with a focus on the pharmacist to implement PINCER. 
Further, participants suggested that involvement of all staff members with PINCER facilitated the 
embedment of the pharmacist within the practice team, a concern identified in previous PINCER 
publications.12
Workshop participants suggested that GPs were key in advocating pharmacists to patients, 
highlighting their knowledge and expertise to build a foundation of trust. Participants in interviews 
felt that patients were less receptive of a medication review with allied health professionals, especially 
if they were not familiar with the healthcare professional or aware of their competencies. From the 
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workshops, PPI participants emphasised longer consultation appointments for medication reviews 
to explain the risks and benefits of medications to facilitate self- management and empowering of 
patients in their medicines management.
Workshop and interview data highlighted the need for adequate resources in terms of funding and 
time for training in engaging across the practice team, with PINCER perceived as a core patient safety 
intervention involving the role of all practice staff members. Workshop and documentary analysis 
data4,13 indicated that the ‘ideal’ scenario would be for PINCER searches to be centrally located 
without the need for additional software, further facilitating use and engagement across the practice 
team.
Strategy for success #4: Achieving engagement with secondary care to 
align prescribing safety guidelines
The data revealed the need to engage with secondary care for alignment of prescribing safety 
guidelines in order to sustain PINCER and CDS. Although alignment with secondary care was 
mentioned by interview participants, this topic was augmented in the workshops, leading to a focus 
on secondary care in the second workshop to explore this theme in depth.
Participants identified the need to align the IT capabilities and infrastructure between primary and 
secondary care. Participants claimed that there was a mismatch in IT systems between secondary and 
primary care to align prescribing safety guidelines between the two sectors:
‘… for PINCER to be able to get the hospital data, it needs some sort of shared care record, 
infrastructure, which I guess isn’t really available within practice systems at the moment.‘ 
(Interview participant, Researcher, PRoTeCT research team)
This effort would need to involve stakeholders of both sectors, including patients and the public, 
underscoring the need to involve multiple organisations, as similarly noted in the documentary 
analysis.4,11,14 The importance of ‘buy- in’ from various organisations was a recurrent theme in the 
data. Participants highlighted the need for involvement of key influencer bodies in supporting the 
interventions and/or structured medication reviews. This was also asserted to be essential in achieving 
nationwide training for PINCER with the engagement of higher education institutes and educational 
bodies in incorporating training at undergraduate and postgraduate levels, additionally supporting 
the alignment of primary and secondary care.
Participants highlighted the need to improve communication between primary and secondary care 
in optimising medications as there was the potential for missed communication regarding medications 
owing to workload. They also suggested that discussions needed to occur across the NHS regarding 
prescribing safety involving patients and healthcare providers, with PINCER training and development 
of indicators as part of this system- wide discussion to align guidelines for secondary and primary care.
Strategy for success #5: Emphasising complementary use of PSI-based 
interventions
Several participants highlighted the need to emphasise the potential for complementary use of PSI- 
based interventions in enhancing patient safety, in order to address any decision by some organisations 
to implement one PSI- based intervention in favour of the other. Participants across workshops and 
interviews saw PINCER and CDS systems as complementary in enhancing prescribing safety:
‘We describe it as being PINCER is your annual MOT of your car and [CDS system] is your 
dashboard, OK so [CDS] is able to tell you in the moment where your issues are and what is 
happening but your PINCER work is what you’re dipping in and out of every kind of three to six 
months.’ (Interview participant, primary care data manager)
Emphasising complementarity was similarly seen as a strategy for adoption and subsequent 
sustainability in the documentary analysis.9,15 An important approach to supporting complementary 
use of PSI- based interventions, as suggested by participants, was the publication of prescribing safety 
data to demonstrate the benefits and impact of concurrent use of PINCER and CDS. Publishing 
such data was also suggested to share learning and best practice between practices and regions, 
additionally acting as a driver to implement the interventions and/or structured medication reviews. 
Publishing prescribing safety data according to localities was suggested to be made available in the 
Shamsuddin A et al. BJGP Open 2021; DOI: 10.3399/BJGPO.2021.0109
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public domain, and hence should be developed in collaboration with PPI partners. The data to be 
published was suggested by participants to focus primarily on PINCER indicators and where localities 
sit within them to further support sustainability of the PSI- based interventions.
Discussion
Summary
Five key strategies have been successfully developed supporting the effective implementation, 
impact, and sustainable use of PSI- based interventions in primary care. The sequential study design 
has ensured that these strategies are grounded in the experiences and perceptions of key stakeholders 
at different levels of the healthcare system. As attention focuses on improving medication safety 
following the WHO's third global patient safety challenge, the findings directly address this call for 
action. This has been achieved by focusing on high- risk prescribing (PSIs) and delivering a resource that 
may be used by policymakers and healthcare managers to enhance prescribing safety in primary care, 
which can additionally be aligned with secondary care. Unpacking the five key strategies illuminates 
the importance of alignment of services, taking a team approach across the healthcare system, and 
sharing information in sustaining the delivery and impact of PSI- based interventions designed to 
improve prescribing safety. The role of support from organisations from local to national levels was 
also clear, in terms of resources and advocating the interventions by key healthcare leaders.
Strengths and limitations
The study adopted a sequential, in- depth exploration of the issues relating to the optimisation 
and sustainability of PINCER and CDS from the available literature and stakeholder experiences. It 
used different methods to draw lessons to inform strategies designed to support the sustainable 
impact of PSI- based interventions in the longer term. The qualitative nature of the study enabled rich 
perspectives into the issues raised by participants to be explored and triangulation of multiple sources 
of data (documents, interviews, and workshops) corroborated analytical findings.16 The sequential 
approach to data collection (that is, documentary analysis, semi- structured interviews, and then 
workshops), with findings from one phase informing the next phase, further connected the emerging 
data and added rigour to the approach. The participants included stakeholders who varied in age and 
experience in primary care across multiple organisations, ranging from NHS England to professional 
and educational bodies and medicines optimisation teams, to ensure the relevance of findings to both 
research and practice.
The study also has important limitations. While several patient and public groups were contacted 
and invited to participate, only groups with particular interest in medication safety responded with 
interest, thus the views of wider patient and public groups were not included. Similarly, clinician 
participants in the interviews and workshops were often directly involved with medication safety 
interventions and were likely to recognise and understand the burden of drug- related harm, and this 
may, therefore, not be representative of wider professional groups. Additionally, the literature search 
for the documentary analysis was not a systematic review, thus some relevant literature may have been 
missed, although the risk of this was minimised by examining the reference lists of included studies 
and obtaining recommendations from the wider research team.
Comparison with existing literature
The importance of a team approach to the delivery of primary care services is well known,10,17 
although increasing evidence pointing to the role of the pharmacist in enhancing prescribing 
safety within general practice continues to emerge.18–21 Historically, scholars have suggested the 
integration of the pharmacist in primary care, using examples of pockets of primary care services 
with dedicated pharmacy input. Pharmacists within the Department of Veterans Affairs (VA) in the US 
have been reported to play a vital role within the healthcare team in providing recommendations to 
prescribers, collaborating with healthcare teams in secondary care, providing preventive medicine 
services, managing the VA drug formulary, and establishing the file structure and clinical pathways for 
prescribing in healthcare information technologies.20 A study in the UK placed pharmacists in general 
practices with roles ranging from patient consultations to managing long- term conditions, medicines 
optimisation, and reconciliation of discharge summaries.22 Positive experiences and decreased 
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workloads were among the outcomes of the study; however, pharmacists in that study echoed the 
present study's findings in underscoring the need for further training and outlining clear job roles to 
fully function in primary care.22 Contemporary studies have highlighted the importance of involving 
the wider general practice team in prescribing safety interventions,23–25 supporting the present 
findings on taking a team approach across primary care to sustain PSI- based interventions. While the 
integration of pharmacists in general practice continues to be a positive development,26,27 the findings 
indicate that other healthcare professionals may lead interventions such as PINCER effectively. This 
could additionally expedite the adoption of services in areas where pharmacists are not yet available 
to support general practice owing to recruitment issues for the pharmacy profession in general 
practice.28,29 Taking a team approach with the training and implementation of PSI- based interventions 
importantly builds sustainability by not relying on particular individuals for the sustainability of the 
intervention by spreading ownership across healthcare professions.30
The findings also point to the need for collaborations of key influencer bodies and patient and 
public groups at all levels to support embedding of PSI- based interventions in general practices across 
England. At a local level it is vital that the trajectory of conversations between stakeholders31 reflects 
local needs and fosters ownership. Other studies that have explored changing prescribing practice in 
primary care also recognise the need for flexibility and tailoring strategies according to local resources 
in engaging general practices.32,33
A previous study has found that prescribers were more likely to engage with prescribing change 
interventions if they perceived it to be an important patient safety issue rather than one that focused on 
cost reduction.33 This is consistent with the findings on engaging the professional values of prescribers 
and practice staff members, in this case on the quality of patient care. Further engagement and impact 
was seen in studies that used local leaders as champions of prescribing change interventions.34–36 
A study investigating the role of champions in primary care change found that champions at both 
the project and organisational levels were critical in driving innovation- specific and transformative 
change,35 echoing participants in the present study in suggesting the need for champions at local and 
national levels. A commonality in these studies is the additional finding of the effectiveness of audit 
and feedback approaches in pushing forward changes in prescribing practice.
Peer- comparison data were found as a significant motivator for changing prescribing practices, even 
without any financial incentives, although this has been suggested to maximise impact.32,37 Collecting 
and showing data on the magnitude of the problem, seen here as potentially hazardous prescribing, 
is an important part of convincing stakeholders of the urgency of the problem.30 Therefore, publishing 
data on the impact of PSI- based interventions on patient harm can further support engagement and 
uptake of these interventions.
Implications for practice
Strong leadership is needed at local and national levels to champion prescribing safety in primary 
care. The importance of taking a team approach to prescribing safety interventions in general practice 
must also be recognised. While the gradual change of employing pharmacists in general practice is 
encouraging, the study underscores a team- based approach to prescribing safety. Correspondingly, 
consistent training for pharmacists at undergraduate and postgraduate level to maximise their role in 
general practice needs to be considered, encompassing the use of PSI- based interventions, quality 
improvement, and root- cause analysis for identifying and preventing potentially hazardous prescribing. 
This training may also incorporate the value of sharing learning across practices, forming a learning 
network among practices, and complementing the public availability of prescribing safety data.
Publishing prescribing safety data according to localities and consistent with prescribing safety 
indicators would sustain PSI- based interventions and encourage friendly competitiveness in enhancing 
prescribing safety. Patients and the general public have an important role to play in prescribing safety, 
hence their involvement should be central to the publication of prescribing safety data alongside 
efforts to empower patients in understanding the role of pharmacists in general practice.
Importantly, policies and guidelines for prescribing safety should align throughout the healthcare 
system and facilitate communication between primary and secondary care. The endeavour to align 
policies could identify challenges and create communication channels for future joined- up care. PSI- 
based interventions should also align with national and local agendas and policies to be flexible to local 
strategies to demonstrate local relevance with national significance that will support sustainability.
Shamsuddin A et al. BJGP Open 2021; DOI: 10.3399/BJGPO.2021.0109
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